Journal
TOXICON
Volume 146, Issue -, Pages 151-175Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.toxicon.2018.03.004
Keywords
Antivenom; Venom; Recombinant antivenom; Antibodies; Snakebite; Scorpion sting; Spider bite; Animal envenoming; Pharmacokinetics; Pharmacodynamics; Immunogenicity; Venom neutralization; Antibody expression; Antivenom design; Adverse reactions; Neglected tropical diseases; Biotechnology
Categories
Funding
- Novo Nordisk Foundation [NNF16OC0019248, NNF13OC0005613]
- Ministerio de Ciencia, Tecnologia y Telecomunicaciones (MICITT) [PEM-066-2015-II]
- Universidad de Costa Rica (UCR) [OAICE-CAB-05-56-2016]
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
- National Council for Scientific and Technological Development [150749/2017-1]
Ask authors/readers for more resources
Antibody technologies are being increasingly applied in the field of toxinology. Fuelled by the many advances in immunology, synthetic biology, and antibody research, different approaches and antibody formats are being investigated for the ability to neutralize animal toxins. These different molecular formats each have their own therapeutic characteristics. In this review, we provide an overview of the advances made in the development of toxin-targeting antibodies, and discuss the benefits and drawbacks of different antibody formats in relation to their ability to neutralize toxins, pharmacokinetic features, propensity to cause adverse reactions, formulation, and expression for research and development (R&D) purposes and large-scale manufacturing. A research trend seems to be emerging towards the use of human antibody formats as well as camelid heavy-domain antibody fragments due to their compatibility with the human immune system, beneficial therapeutic properties, and the ability to manufacture these molecules cost-effectively. (C) 2018 The Authors. Published by Elsevier Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available